ZA931184B - The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation - Google Patents
The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulationInfo
- Publication number
- ZA931184B ZA931184B ZA931184A ZA931184A ZA931184B ZA 931184 B ZA931184 B ZA 931184B ZA 931184 A ZA931184 A ZA 931184A ZA 931184 A ZA931184 A ZA 931184A ZA 931184 B ZA931184 B ZA 931184B
- Authority
- ZA
- South Africa
- Prior art keywords
- atoms
- interruption
- radical
- treatment
- blood circulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4205424 | 1992-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA931184B true ZA931184B (en) | 1993-09-16 |
Family
ID=6452327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA931184A ZA931184B (en) | 1992-02-22 | 1993-02-19 | The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0557876B1 (xx) |
JP (1) | JP3193800B2 (xx) |
KR (1) | KR930017580A (xx) |
AT (1) | ATE146078T1 (xx) |
AU (1) | AU658979B2 (xx) |
CA (1) | CA2089959A1 (xx) |
DE (1) | DE59304710D1 (xx) |
DK (1) | DK0557876T3 (xx) |
ES (1) | ES2096115T3 (xx) |
GR (1) | GR3022183T3 (xx) |
HU (1) | HUT64472A (xx) |
TW (1) | TW288977B (xx) |
ZA (1) | ZA931184B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3792266B2 (ja) * | 1994-06-16 | 2006-07-05 | 森精機興産株式会社 | 工作機械の熱変位補正方法及びその装置 |
DE19540798A1 (de) * | 1995-11-02 | 1997-05-07 | Hoechst Ag | Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
US20070105878A1 (en) * | 2005-10-03 | 2007-05-10 | Andrew Reaume | Purine formulations and methods for managing disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH608236A5 (xx) * | 1974-01-22 | 1978-12-29 | Wuelfing J A Fa | |
DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
GB8621870D0 (en) * | 1986-09-11 | 1986-10-15 | Beecham Group Plc | Active compounds |
ATE138266T1 (de) * | 1990-11-07 | 1996-06-15 | Hoechst Roussel Pharma | Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren |
-
1993
- 1993-02-17 DE DE59304710T patent/DE59304710D1/de not_active Expired - Lifetime
- 1993-02-17 TW TW082101087A patent/TW288977B/zh active
- 1993-02-17 DK DK93102450.9T patent/DK0557876T3/da active
- 1993-02-17 EP EP93102450A patent/EP0557876B1/de not_active Expired - Lifetime
- 1993-02-17 ES ES93102450T patent/ES2096115T3/es not_active Expired - Lifetime
- 1993-02-17 AT AT93102450T patent/ATE146078T1/de not_active IP Right Cessation
- 1993-02-19 AU AU33761/93A patent/AU658979B2/en not_active Ceased
- 1993-02-19 JP JP02951693A patent/JP3193800B2/ja not_active Expired - Lifetime
- 1993-02-19 ZA ZA931184A patent/ZA931184B/xx unknown
- 1993-02-19 CA CA002089959A patent/CA2089959A1/en not_active Abandoned
- 1993-02-22 HU HU9300476A patent/HUT64472A/hu unknown
- 1993-02-22 KR KR1019930002426A patent/KR930017580A/ko not_active Application Discontinuation
-
1996
- 1996-12-30 GR GR960403651T patent/GR3022183T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUT64472A (en) | 1994-01-28 |
ES2096115T3 (es) | 1997-03-01 |
GR3022183T3 (en) | 1997-03-31 |
DE59304710D1 (de) | 1997-01-23 |
EP0557876B1 (de) | 1996-12-11 |
KR930017580A (ko) | 1993-09-20 |
AU658979B2 (en) | 1995-05-04 |
HU9300476D0 (en) | 1993-05-28 |
JPH069634A (ja) | 1994-01-18 |
AU3376193A (en) | 1993-08-26 |
TW288977B (xx) | 1996-10-21 |
CA2089959A1 (en) | 1993-08-23 |
DK0557876T3 (da) | 1997-05-26 |
JP3193800B2 (ja) | 2001-07-30 |
EP0557876A1 (de) | 1993-09-01 |
ATE146078T1 (de) | 1996-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK139287A (da) | Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler | |
HU896769D0 (en) | Fungicide compositions comprising azolylmethylcyclopentane-benzylidene-derivatives as active ingredient and process for preparation of the active ingredients | |
FI912998A (fi) | Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror. | |
SE9100342D0 (sv) | Novel steroid esters | |
HUT59394A (en) | Process for producing piperazine derivatives and pharmaceutical compositions comprising same | |
AU584274B2 (en) | Process for the crosslinking of organopolysiloxanes | |
TW288977B (xx) | ||
IL91913A0 (en) | Fluorosubstituted benzene derivatives,processes for the preparation thereof and diagnostic compositions containing the same | |
EP0528164A3 (xx) | ||
ATE121405T1 (de) | Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
GR3015512T3 (en) | Thiophene derivatives, process for their preparation and pharmaceutical compositions containing them. | |
GR890300045T1 (en) | Process for the preparation of 2,5-diamino-nitro-6-pyridine derivatives, their use in hair dyeing agents and these 2,5-diamino-6-nitro-pyridine derivatives | |
EP0484785A3 (en) | Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses | |
NZ216125A (en) | Isoxazoles and pharmaceutical compositions | |
ES2096800T3 (es) | Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos. | |
FI950259A0 (fi) | Uudet, asykliset, amidiiniryhmiä sisältävät difosfonihappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet | |
SE7412163L (xx) | ||
HU906462D0 (en) | Process for producing substituted 20,21-dinoreburnamenine | |
RU93004489A (ru) | Лекарственное средство для профилактики и лечения повреждений мышц после прерывания кровообращения и способ лечения |